ZM001

ZM001 · Beijing Immunochina Medical Science & Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZM001, covering 2025-02-28 to 2025-02-28. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of ZM001 Injection in the Treatment of Refractory Systemic Lupus Erythematosus [Phase 1]